Powala Christopher

CIK 00016543011 companyMALVERN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001654301

Recent Transactions

27 trades

Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2019-02-01$6.96/sh−1,114→ 141,729 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2019-02-01−3,400→ 10,200 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2019-02-01+3,400→ 142,843 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2018-12-18−1,625→ 1,625 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-12-18+1,625→ 139,889 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-12-18$6.30/sh−446→ 139,443 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-12-15+1,300→ 138,621 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-12-15$7.31/sh−357→ 138,264 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2018-12-15−1,300→ 2,600 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2018-05-07−5,200→ 3,900 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-05-07+5,200→ 138,801 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-05-07$18.10/sh−1,480→ 137,321 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2018-02-01+47,600→ 47,600 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2018-02-01+13,600→ 13,600 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-12-18+1,625→ 134,095 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-12-18$24.12/sh−494→ 133,601 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2017-12-18−1,625→ 3,250 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-12-15$24.23/sh−395→ 132,470 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-12-15+1,300→ 132,865 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2017-12-15−1,300→ 9,100 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2016-12-18+1,625→ 132,059 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2016-12-18$31.25/sh−494→ 131,565 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2016-12-18−1,625→ 4,875 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2016-12-15+62,400→ 62,400 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2016-12-15+10,400→ 10,400 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2015-12-18+58,516→ 58,516 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2015-12-18+6,500→ 6,500 total

Companies

Aclaris Therapeutics, Inc.
Chief Operating Officer
$ACRS

Recent Filings

Address

C/O ACLARIS THERAPEUTICS, INC. 101 LINDENWOOD DRIVE, SUITE 400

MALVERN, PA, 19355

View on SEC.gov